S. No | Dataset [Reference] | Disorders | Sample size | Brain regions | No. of DEGs (control vs. diseased brain samples) | RBPs influencing differential expression |
---|---|---|---|---|---|---|
1 | GSE53987 [44] | MDD, BD, and SCZ | BD:18–19 Control:17–19; SCZ:15–18 | Hippocampus, PFCa, and striatum | MDD and BD: none; SCZ: 4835 (hippocampus), 19 (PFC) | NA |
2 | GSE92538 [45] | MDD, BD, and SCZ | BD: 12 Control: 56 MDD: 29 SCZ:31 | DLPFCb | BD: none; SCZ: 681; MDD: 1760 | MDD: 97 SCZ: 94 |
3 | GSE120340 [46] | BD and SCZ | BD with psychosis: 6 BD without psychosis: 4 SCZ: 10 Control: 10 | DLPFCb | None | NA |
4 | GSE35977 [47] | BD, depression, and SCZ | BD: 45 Control: 50 Depression: 14 SCZ: 51 | Parietal cortex | BD and depression: none; SCZ: 38 | NA |
5 | GSE35974 [48] | BD, depression, and SCZ | BD: 37 Control: 50 Depression: 13 SCZ: 44 | Cerebellum | BD: 953; depression: 6; SCZ: 373 | BD: 15 SCZ: 1 |
6 | GSE12679 [49] | BD and SCZ | BD: 5 Control: 5–6 SCZ: 11 | Endothelial cells/neurons isolated from post-mortem DLPFCb | None | NA |